Eyecheq raises $9.95M to prevent blindness

What's the deal? EyecheqDealroom has a profile for this one. Try Dealroom → has raised $9.95 million through a private placement, according to a Form D filed with the U.S. Securities and Exchange Commission.

The offering is structured to raise up to $11.5 million in total, leaving roughly $1.55 million still on the table.

The company plans to use the funds for general corporate purposes, including research and development, operational expenses, and strategic opportunities.

Why now? The filing, dated June 2026, was conducted under Regulation D, which lets companies sell securities privately without a public registration statement. The offering is limited to accredited investors, with no public advertising involved.

What could go wrong? Eyecheq has not disclosed the number of shares issued or the price per share, leaving key terms unclear. The round also remains short of its $11.5 million target, and there's no guarantee it closes in full.

The signal: Eyecheq pitches itself as a startup on a mission to prevent blindness, placing this raise within the broader wave of early-stage capital flowing into vision and ophthalmic health. As an early-stage company, securing nearly $10 million through a private placement suggests investor appetite for preventative eye-care technology, even as the round stops short of its $11.5 million ceiling.

Read more: SEC EDGAR (Form D) · AInvest

Image credit: AMISOM Public Information